Jazz Pharmaceuticals plc (JAZZ)

NMS – Real Time Price. Currency in USD

250.35

+2.37 (0.95%)

Market open: Aug 12, 2026, 3:06 PM EDT

248.05

+0.07 (0.03%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

4.27B

4.07B

3.83B

3.66B

Cost of goods sold

-1.16B

-1.07B

-1.04B

-1.14B

Gross Profit

3.11B

2.79B

2.52B

Operating expenses (excl. COGS)

-2.36B

-2.27B

-2.13B

-1.80B

Operating Income

751M

727M

659M

720M

Non-operating income, total

-1.38B

-256M

-361M

-1.09B

Pretax income

-628M

470M

298M

-373M

Equity in earnings

-732K

-2M

-3M

-10M

Taxes

272M

91M

120M

159M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-356M

560M

415M

-224M

Discontinued operations

Net income

-356M

560M

415M

-224M

Dilution adjustment

11M

25M

Preferred dividends

Jazz Pharmaceuticals plc (JAZZ)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Jazz Pharmaceuticals plc (JAZZ)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Jazz Pharmaceuticals plc (JAZZ)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Jazz Pharmaceuticals plc (JAZZ)

Income Statement (Annual)

Income Statement (Annual)